Ligand binding to integrin αvβ3requires tyrosine 178 in the αv subunit

Slides:



Advertisements
Similar presentations
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Advertisements

Figure 8. Colocalization of β-Arrestin2-GFP with Internalized wt and S(483–498)A Mutant PTHRs HEK-wt PTHR and HEK-S(483–498)A PTHR cells were transiently.
DISSECTING THE EPITOPE FOR THE 7E3 mAb BY GENERATING HUMAN/MOUSE
MHC class II/CD38/CD9: a lipid-raft–dependent signaling complex in human monocytes by Marie-Thérèse Zilber, Niclas Setterblad, Thierry Vasselon, Christelle.
Evidence for the multimeric structure of ferroportin
Two novel mutations in the αIIb calcium-binding domains identify hydrophobic regions essential for αIIbβ3 biogenesis by W. Beau Mitchell, Ji Hong Li, Fiza.
Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets by Gerlinde R. Van de Walle, Anne Schoolmeester,
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Transglutaminase-mediated oligomerization of the fibrin(ogen) αC domains promotes integrin-dependent cell adhesion and signaling by Alexey M. Belkin, Galina.
by Koji Nakamura, Alexander Malykhin, and K. Mark Coggeshall
The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC Promotes Degradation of the Transferrin Receptor  Lior Horonchik, Marianne Wessling-Resnick 
by Kesheng Dai, Richard Bodnar, Michael C. Berndt, and Xiaoping Du
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases.
Β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome by Kenji Tanimura, Hui Jin, Tadahiro Suenaga, Satoko Morikami,
by Mineo Iwata, Lynn Graf, Norihiro Awaya, and Beverly Torok-Storb
Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor γ-chain signaling by Li Shen, Marjolein van.
Volume 3, Issue 6, Pages (June 2013)
Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II by Domenick J. Falcone, Wolfgang Borth,
Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9 by Miguel Angel de la Fuente, Victoria.
by Fawzi Aoudjit, and Kristiina Vuori
OX40 Expressed on Fresh Leukemic Cells From Adult T-Cell Leukemia Patients Mediates Cell Adhesion to Vascular Endothelial Cells: Implication for the Possible.
Annexin A2 tetramer activates human and murine macrophages through TLR4 by Jennifer F. A. Swisher, Nicholas Burton, Silvia M. Bacot, Stefanie N. Vogel,
ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding by Ana Kasirer-Friede, Jian Kang, Bryan.
Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1 by Nijing Sheng,
Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin αIIbβ3) and the platelet-activating.
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
by Daniel W. Bougie, Ana I. Benito, Luis I
Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors by Caroline A. Evans, Shahrul Ariffin,
A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (αIIbβ3) integrin receptor locked in a.
Α-Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation.
RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor.
by Jun Chung, Xue-Qing Wang, Frederik P. Lindberg, and William A
Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A by Hirokazu Kashiwagi, Masamichi Shiraga, Hisashi Kato, Tsuyoshi.
A Mechanism for Modulation of Cellular Responses to VEGF
by Abdelbaset Elzagallaai, Sergio D. Rosé, and José-Marı́a Trifaró
A role for the thiol isomerase protein ERP5 in platelet function
A potential role for α-actinin in inside-out αIIbβ3 signaling
Integrin-linked kinase associated with integrin activation
by Chungho Kim, Tong-Lay Lau, Tobias S. Ulmer, and Mark H. Ginsberg
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions by Claire Abbal, Martine Lambelet, Debora Bertaggia, Carole.
DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines by Hiroshi Nishihara, Masae Maeda, Atsushi Oda, Masumi Tsuda, Hirofumi Sawa,
Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33 by Ann L. Cornish, Sylvie Freeman, Gareth Forbes, Jian Ni,
by Xingming Deng, Fengqin Gao, and W. Stratford May
Chronic neutropenia mediated by Fas ligand
by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong
Specific Lysis of Melanoma Cells by Receptor Grafted T Cells is Enhanced by Anti- Idiotypic Monoclonal Antibodies Directed to the scFv Domain of the Receptor 
A Three Amino Acid Deletion in Glycoprotein IIIa Is Responsible for Type I Glanzmann's Thrombasthenia: Importance of Residues Ile325Pro326Gly327 for β3.
Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of vβ3 Integrin and Enhances β1 Integrin-Mediated Adhesion of Eosinophils.
by Bindu Varghese, Adam Widman, James Do, Behnaz Taidi, Debra K
CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress by Anja Meissner, Olaf Zilles, Rosa.
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Volume 115, Issue 2, Pages (August 1998)
Volume 64, Issue 2, Pages (August 2003)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Figure 3. MAb 19H9 displays broad cross-reactivity with IAV strains of different subtypes. (A), Amino acid sequence ... Figure 3. MAb 19H9 displays broad.
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe 
Volume 25, Issue 5, Pages (November 2006)
Volume 11, Issue 4, Pages (February 2001)
Silva H Hanissian, Raif S Geha  Immunity 
IgG Autoantibodies from Bullous Pemphigoid (BP) Patients Bind Antigenic Sites on Both the Extracellular and the Intracellular Domains of the BP Antigen.
Volume 57, Issue 2, Pages (October 2000)
Integrin α3β1 (CD 49c/29) Is a Cellular Receptor for Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) Entry into the Target Cells  Shaw M. Akula,
Volume 64, Issue 2, Pages (August 2003)
Volume 8, Issue 2, Pages (February 1998)
Volume 7, Issue 6, Pages (December 1997)
Volume 23, Issue 2, Pages (August 2005)
Characterization of the complex formed at the Fra-1 RCE1.
Presentation transcript:

Ligand binding to integrin αvβ3requires tyrosine 178 in the αv subunit by Shigenori Honda, Yoshiaki Tomiyama, Nisar Pampori, Hirokazu Kashiwagi, Teruo Kiyoi, Satoru Kosugi, Seiji Tadokoro, Yoshiyuki Kurata, Sanford J. Shattil, and Yuji Matsuzawa Blood Volume 97(1):175-182 January 1, 2001 ©2001 by American Society of Hematology

Amino acid sequences of the predicted W3 4-1 loop between the N-terminal repeats 2 and 3 and the predicted W3 2-3 loop within repeat 3 in the α subunits of β3 integrins.Both loops are located on the upper face of the β-propeller model.20 The asterisks indic... Amino acid sequences of the predicted W3 4-1 loop between the N-terminal repeats 2 and 3 and the predicted W3 2-3 loop within repeat 3 in the α subunits of β3 integrins.Both loops are located on the upper face of the β-propeller model.20 The asterisks indicate that the residues were substituted by alanine in this study. This figure is adapted from a β-propeller model proposed by Springer,20 and the arrows indicate β strands. Shigenori Honda et al. Blood 2001;97:175-182 ©2001 by American Society of Hematology

Surface expression of αvβ3mutants in transiently transfected 293 cells Surface expression of αvβ3mutants in transiently transfected 293 cells.(A) The surface expression of transfected αvβ3 was analyzed 2 days after transfection by flow cytometry. Surface expression of αvβ3mutants in transiently transfected 293 cells.(A) The surface expression of transfected αvβ3 was analyzed 2 days after transfection by flow cytometry. Cells expressing WT or mutant αvβ3 were incubated with 5 μg/mL αvβ3 complex-specific mAb LM609 for 30 minutes on ice and then washed once. Bound antibodies were detected by FITC-conjugated goat F(ab′)2 antimouse IgG. Relative amounts of the binding were normalized to a 100% value for LM609 binding to cells expressing WT αvβ3. The results are representative of 3 separate experiments. (B) Immunoprecipitation showing the surface expression of transfected αvβ3. Transiently transfected cells were surface-labeled with sulfo-NHS-biotin and lysed in the lysing buffer containing 1% Triton X-100. WT or mutant αvβ3 was precipitated with LM609 (specific for the αvβ3 complex) and separated on a 6% sodium dodecyl sulfate polyacrylamide gel under reducing conditions. After transfer, a membrane was incubated with peroxidase-conjugated avidin and developed with chemiluminescence. The results are representative of 3 separate experiments. Shigenori Honda et al. Blood 2001;97:175-182 ©2001 by American Society of Hematology

Ligand-binding function of αvβ3 mutants Ligand-binding function of αvβ3 mutants.(A) The binding of soluble fibrinogen and a ligand-mimetic mAb, WOW-1 Fab, to WT or mutant αvβ3 were examined in the presence or absence of 0.5 mM MnCl2 by flow cytometry. Ligand-binding function of αvβ3 mutants.(A) The binding of soluble fibrinogen and a ligand-mimetic mAb, WOW-1 Fab, to WT or mutant αvβ3 were examined in the presence or absence of 0.5 mM MnCl2 by flow cytometry. For fibrinogen binding, washed cells were first incubated with 5 μg/mL mAb LM142 (specific for αv) for 30 minutes on ice. After washing, cells with 0.5 mM MnCl2 were incubated with 150 μg/mL FITC-conjugated fibrinogen and PE-conjugated antimouse IgG (1:5 dilution) for 25 minutes at 22°C and then incubated with PI for 5 minutes at 22°C. After washing, fibrinogen binding (FL1) was analyzed on the gated subset of single, high αvβ3 expression (FL2) and live cells (PI-negative, FL3) as indicated. (B) Relative amounts of fibrinogen binding are normalized to a 100% value for the binding to cells expressing WT αvβ3 (% of WT). Fibrinogen binding in the presence of 1 mM RGDW was used as a negative control. Data represent the mean ± SE of 3 experiments. (C) WOW-1 Fab binding. For WOW-1 binding, cells with 0.5 mM MnCl2 were first incubated with 5 μg/ml WOW-1 Fab for 30 minutes at 22°C. After washing, cells were incubated with 5 μg/mL Alexa-conjugated antimouse IgG for 25 minutes on ice and then incubated with PI for 5 minutes at 22°C. After washing, bound antibodies were analyzed. WOW-1 binding to 293 cells was used as a negative control. Relative amounts of WOW-1 Fab binding are expressed by the following formula: % binding of WOW-1 Fab to WT αvβ3/% binding of LM609 to WT αvβ3. The αvαIIb mutant represents a chimera in which the C142-C155 loop in αv was swapped with the corresponding sequence of αIIb C146-C167. Data represent the mean ± SE of 3 experiments. Shigenori Honda et al. Blood 2001;97:175-182 ©2001 by American Society of Hematology

Effects of β3-activating mutant (T562N) on fibrinogen binding Effects of β3-activating mutant (T562N) on fibrinogen binding.WT (▪) or Y178Aαv (■) construct was transiently cotransfected with WT or T562Nβ3 construct into 293 cells. Effects of β3-activating mutant (T562N) on fibrinogen binding.WT (▪) or Y178Aαv (■) construct was transiently cotransfected with WT or T562Nβ3 construct into 293 cells. Fibrinogen binding to transfected αvβ3 was determined by flow cytometry. Cells were first incubated with 5 μg/mL LM142 (specific for αv) for 30 minutes on ice. After washing, cells were incubated with 150 μg/mL FITC-conjugated fibrinogen and PE-conjugated antimouse IgG for 25 minutes at 22°C in the presence or absence of 1 mM RGDW and then incubated with PI for 5 minutes at 22°C. After washing, cells expressing high levels of transfected αvβ3 were analyzed. In these experiments, all were performed in the absence of MnCl2. The results are representative of 3 separate experiments. Shigenori Honda et al. Blood 2001;97:175-182 ©2001 by American Society of Hematology

LIBS expression on Y178Aαvβ3mutant LIBS expression on Y178Aαvβ3mutant.WT or Y178Aαv construct was transiently cotransfected with WT β3 construct into 293 cells. LIBS expression on Y178Aαvβ3mutant.WT or Y178Aαv construct was transiently cotransfected with WT β3 construct into 293 cells. Three different mAbs specific for β3 LIBS (AP5, anti-LIBS1, and anti-LIBS6) were employed to assess the LIBS expression, and LM609 (specific for αvβ3) was employed to monitor the surface expression of transfected αvβ3. (A) LIBS expression in the absence of RGDW peptide. Closed and open histograms represent the binding of anti-LIBS antibodies and control mouse IgG1, respectively. The results are representative of 2 separate experiments. (B) LIBS expression in the presence (▪) or absence (■) of 1 mM RGDW peptide. Closed and open histograms represent the binding of anti-LIBS antibodies in the presence and absence of RGDW, respectively. The results are representative of 2 separate experiments. Shigenori Honda et al. Blood 2001;97:175-182 ©2001 by American Society of Hematology

Adhesion of αvβ3 mutants to immobilized fibrinogen Adhesion of αvβ3 mutants to immobilized fibrinogen.WT or mutant αv construct was transiently cotransfected with WT β3 construct into 293 cells. Adhesion of αvβ3 mutants to immobilized fibrinogen.WT or mutant αv construct was transiently cotransfected with WT β3 construct into 293 cells. In WT β3 cells (⋄), only WT β3 construct was transfected into cells. WT (○) or mutant αvβ3-transfected cells were incubated for 60 minutes at 37°C with immobilized fibrinogen at serial concentrations. After washing with PBS, the adherent cells were quantified with a colorimetric reaction using endogenous cellular acid phosphatase activity. ▵, Phe177Ala; ✙, Tyr178Ala; ▿, Trp179Ala; ■, untransfected cells. Data represent the mean ± SE of triplicate measures of optical density at 415 nm. Shigenori Honda et al. Blood 2001;97:175-182 ©2001 by American Society of Hematology

Critical residues for ligand binding in the α subunits of β3 integrins Critical residues for ligand binding in the α subunits of β3 integrins.(A) Comparison of critical residues for ligand binding in αv with those in αIIb. Critical residues for ligand binding in the α subunits of β3 integrins.(A) Comparison of critical residues for ligand binding in αv with those in αIIb. In αIIb multiple residues (underlined) critical for ligand binding have been identified in both the W3 4-1 and W3 2-3 loops. In sharp contrast, in αv only Y178 within the W3 2-3 loop is critical for ligand binding. The figures in panels B and C are adapted from a β-propeller model proposed by Springer,20 and they show the location of these critical residues. The view is shown from the top (B) and from the side (C). Shigenori Honda et al. Blood 2001;97:175-182 ©2001 by American Society of Hematology